Victory Capital Management Inc Homology Medicines, Inc. Transaction History

Victory Capital Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$9.17 - $14.8 $761,467 - $1.23 Million	-83,039 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$8.92 - $13.29 $143,701 - $214,101	-16,110 Reduced 16.25%	83,039 $938,000
Q3 2020 Nov 09, 2020	SELL	$9.94 - $16.59 $37,573 - $62,710	-3,780 Reduced 3.67%	99,149 $1.06 Million
Q2 2020 Aug 07, 2020	SELL	$12.07 - $19.34 $2.86 Million - $4.58 Million	-236,829 Reduced 69.71%	102,929 $1.56 Million
Q1 2020 May 04, 2020	SELL	$12.5 - $22.04 $196,900 - $347,174	-15,752 Reduced 4.43%	339,758 $5.28 Million
Q4 2019 Feb 06, 2020	BUY	$11.42 - $22.19 $61,039 - $118,605	5,345 Added 1.53%	355,510 $7.36 Million
Q4 2019 Feb 04, 2020	SELL	$11.42 - $22.19 $375,695 - $730,006	-32,898 Reduced 8.59%	350,165 $5.48 Million
Q3 2019 Nov 12, 2019	BUY	$14.74 - $22.28 $3.7 Million - $5.59 Million	250,904 Added 189.85%	383,063 $6.93 Million
Q2 2019 Aug 15, 2019	BUY	$18.35 - $30.34 $917,133 - $1.52 Million	49,980 Added 60.82%	132,159 $2.59 Million
Q1 2019 May 03, 2019	SELL	$19.76 - $29.57 $84,375 - $126,263	-4,270 Reduced 4.94%	82,179 $2.28 Million
Q4 2018 Feb 05, 2019	SELL	$18.39 - $26.3 $27,401 - $39,187	-1,490 Reduced 1.69%	86,449 $1.93 Million
Q3 2018 Nov 01, 2018	SELL	$15.54 - $22.86 $104,133 - $153,184	-6,701 Reduced 7.08%	87,939 $2.01 Million
Q2 2018 Aug 02, 2018	SELL	$16.49 - $21.55 $88,386 - $115,508	-5,360 Reduced 5.36%	94,640 $1.93 Million
Q1 2018 May 04, 2018	BUY	$18.66 - $18.7 $1.87 Million - $1.87 Million	100,000 New	100,000 $1.87 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.